BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Coagulation, Inflammatory disorder, Embryo, Hematopoietic cell, Bleomycin, rs2230926)
Bookmark Forward

QuickView for interleukin 23 subunit p19 (compound)


Genetic Markers

Most Correlated Genes

  1. No genes found
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. No biogroups found
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. CD4+ T cells activated and differentiated with Th17-inducing cytokine combinations
  2. CD4+ T cells differentiation into Th17 cells in the presence of TGF-beta1 and IL-6
  3. Colons of MDR1A KO mice with Helicobacter bilis colitis treated with interleukin blocking antibodies
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasi…
  2. Novel bispecific nanobody mitigates experimental intestinal inflammation in mice by targeting TNF-α …
  3. Antagonistic Peptides That Specifically Bind to the First and Second Extracellular Loops of CCR5 and…
  4. Riemerella anatipestifer infection in ducks induces IL-17A production, but not IL-23p19.
  5. Risankizumab, an IL-23p19 Inhibitor for Psoriasis: A Review of the Current Literature.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic …
  2. Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
  3. Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Sever…
  4. Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
  5. A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Ar…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.